In the context of dramatically increasing food allergy incidence and a breakthrough approval in the field, the Next Generation Food Allergy Drug Development Summit will unite large pharma and innovative biotechs to overcome the unique drug development challenges involved in turning promising food allergy biologics into clinical and commercial realities.
Join us to investigate the latest technological innovations, benchmark against your peers, build global connections and streamline your drug development pipelines for food allergy, with insights being shared from a range of companies and institutions including Aimmune, Camallergy, Allergy Therapeutics, Intrommune, Vedanta Biosciences and University of North Carolina.
Access the official event guide to learn more.
Industry-Leading Speakers Include:
Senior Medical Director
Principal Scientist, Innovation & Product Development
Associate Professor of Medicine & Pediatrics
University of North Carolina School of Medicine
Science Lead, Allergy
VP, Medical Affairs
Reader in Immunology & Allergy
Imperial College London
Co-Founder & CSO
Chief Medical Advisor for Operations/Professor, Medicine and Pediatrics
FARE/University of South Florida, Tampa
Head of Allergy Immunology Research Group
Murdoch Children’s Research Institute and The Royal Children’s Hospital Melbourne